posted
eFoodSafety.com, Inc. Subsidiary, Knock-Out Technologies, Ltd.'s Citroxin O2 Ingestible Kills Avian Influenza in Independent Laboratory Testing; Bucks County Clinical Research Begins Testing on Influenza A and B
Business Editors / Health Editors
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jan. 31, 2006-- Robert Bowker, President/CEO of Knock-Out Technologies, Ltd., a wholly owned subsidiary of eFoodSafety.com, Inc. (OTCBB: EFSF) announced today that Human Clinical Trials on Citroxin O2 ingestible have commenced. In independent laboratory testing, Citroxin O2 killed a strain of the Avian Influenza Virus. Bucks County Clinical Research, Inc., (BCCR) (http://bccrinc.com/), an FDA clinical facility begins testing on Influenza A and B Viruses to substantiate results. The tests are to be conducted under the direction of David J. Miller, D.O., FAAP, Executive Director of BCCR and Richard M. Goldfarb, M.D., FACS, Medical Director of Research & Development of BCCR, a Director of eFoodSafety.com, Inc., and President of MedElite, Inc., a wholly-owned subsidiary of eFoodSafety.com, Inc. After 100% successful eradication of a strain of Avian Influenza Virus in laboratory testing, Knock-Out Technologies will seek to impact in the clinical setting a reduction in severity and length of time influenza virus will affect the human population. Since Avian Influenza Virus cannot be studied in human subjects, we will set out to show the efficacy in the treatment of Influenza Viruses A and B, which mirror the Avian Influenza Virus. "This milestone of testing with Human Clinical Trials with our Citroxin O2 ingestible product will enable us to prove what our laboratory findings have demonstrated. This further allows us as a company, and for the benefit of our shareholders, a product that can be revolutionary in the challenge of the worrisome Avian Influenza Virus," stated Patricia-Ross Gruden, President/CEO of eFoodSafety.com, Inc.
About eFoodSafety.com, Inc.
eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and most recently became a distributor for Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes.
Posts: 5120 | Registered: Jun 2004
| IP: Logged |
Received this info in ChartAdvisor newsletter... -------------------------------- Ground Floor Profit Opportunity from Konrad Kuhn, Editor and Publisher of The KonLin Letter :
Feds Approve Breakthrough for Avian Flu Crisis
Breaking news:
EPA approves eFoodSafety Big Six Plus germicidal (Citroxin), a non-toxic spray that kills bird flu virus surrogate!
Non-toxic formula proven safe for broadscale uses.
Human trials are now underway to test efficacy in infected patients for Influenza A and B.
Agricultural use could soon stop worldwide bird flu pandemic.
Company: eFoodSafety Symbol: EFSF
First Target: $2 Strategy: Buy and hold for sell signal from The KonLin Letter
Recommendation: Immediate BUY NOW!
This is a high risk investment suitable only for aggressive investors. Please limit your investment to an amount you are comfortable putting at risk for loss.
Posts: 27 | From: St. Louis, MO | Registered: Nov 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
